Jessica Renz
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 240 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 16.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,307, 2.5 times the $531 reported in 2021. Among family clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 240 payments — averaging $14.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$586
- Novo Nordisk$514
- Amgen$365
- Astellas Pharma US Inc$271
- Pfizer$219
- Otsuka America Pharmaceutical, Inc.$196
- plus $1K from 25 others
What the payments were for
- Food & beverage$3,544100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 43 | $586 |
| Novo Nordisk | 38 | $514 |
| Amgen | 25 | $365 |
| Astellas Pharma US Inc | 17 | $271 |
| Pfizer | 15 | $219 |
| Otsuka America Pharmaceutical, Inc. | 12 | $196 |
| Lilly USA, LLC | 11 | $152 |
| Bayer | 8 | $134 |
| Lexicon Pharmaceuticals, Inc. | 6 | $116 |
| Johnson & Johnson | 7 | $93 |
| AstraZeneca | 6 | $88 |
| Lundbeck LLC | 5 | $84 |
| Boehringer Ingelheim | 5 | $75 |
| Novartis | 5 | $75 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $68 |
| Sumitomo Pharma America, Inc. | 3 | $55 |
| GSK | 4 | $52 |
| Mylan Specialty L.p. | 3 | $51 |
| Teva Pharmaceuticals USA, Inc. | 3 | $50 |
| Merck | 3 | $49 |
| Seqirus USA Inc | 2 | $40 |
| Phathom Pharmaceuticals, Inc. | 3 | $31 |
| VBI Vaccine (delaware) Inc. | 2 | $31 |
| Biohaven Pharmaceuticals, Inc. | 2 | $29 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $20 |
| Kyowa Kirin, Inc. | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Nestle Healthcare Nutrition Inc. | 1 | $14 |
| Genentech USA, Inc. | 1 | $11 |
How this compares
$3,544 in reported general payments places this provider in the 95th percentile of 1,268 family providers in Iowa.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 21 | $18,719 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 25 | $16,505 |
| EliquisApixaban | 16 | $16,227 |
| JardianceEmpagliflozin | 11 | $7,301 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 11 | $2,416 |
| Gabapentin | 56 | $634 |
| Ropinirole Hcl | 25 | $467 |
| Atorvastatin Calcium | 64 | $463 |
| Omeprazole | 70 | $423 |
| Levothyroxine Sodium | 74 | $415 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 14 | $364 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $325 |
| Duloxetine Hcl | 21 | $322 |
| Azithromycin | 46 | $304 |
| Cefdinir | 17 | $295 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Shingrix | $52 | $18,92136 claims |
| Novo NordiskOzempic | $514 | $18,71921 claims |
| PfizerEliquis | $219 | $16,22716 claims |
| Boehringer IngelheimJardiance | $75 | $7,30111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,268 family providers in Iowa.
Other family in Onawa
- Stefanie GaticaAnkeny$354K
- Aubrey MolgaardAmes$238K
- Joan KittenFort Dodge$85K
- Megan FergusonPella$82K
- Rodney ClarkDes Moines$63K
- Jennifer CondonFort Dodge$31K
- Karen HunkeAmes$20K
- Tonia AckermanWest Des Moines$17K
- Chi-Ying SageWaterloo$14K
- Amanda GaldiNorth Liberty$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.